Concentra Group (CON) EVP, CMO reports 6,540-share tax withholding on vesting

Rhea-AI Filing Summary

Concentra Group Holdings Parent, Inc. executive shares were adjusted in connection with equity compensation. On 11/26/2025, an officer identified as the Executive Vice President and Chief Medical Officer reported a Form 4 transaction in the company’s common stock. A total of 6,540 shares of common stock were disposed of at $21.04 per share under transaction code F, which indicates shares were withheld to cover tax obligations arising from the vesting of restricted stock.

After this tax withholding event, the reporting person directly beneficially owned 113,460 shares of Concentra Group Holdings Parent, Inc. common stock. The filing reflects an administrative adjustment related to equity compensation rather than an open‑market purchase or sale.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Anderson John Robert Jr.

(Last) (First) (Middle)

C/O CONCENTRA GROUP HOLDINGS PARENT, INC

5080 SPECTRUM DRIVE, SUITE 1200W

(Street)

ADDISON TX 75001

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Concentra Group Holdings Parent, Inc. [ CON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
11/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/26/2025		F(1)		6,540	D	$21.04	113,460	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares of common stock withheld to satisfy tax obligations arising out of vesting of restricted stock.

Remarks:

Executive Vice President, Chief Medical Officer

	/s/ Timothy F. Ryan, Attorney-in-Fact	12/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Concentra Group Holdings Parent, Inc. (CON) report?

A company officer reported a Form 4 transaction in common stock on 11/26/2025. The filing shows shares were withheld to cover taxes related to vesting of restricted stock, rather than an open-market trade.

How many Concentra Group Holdings Parent, Inc. (CON) shares were involved in the Form 4?

The Form 4 reports that 6,540 shares of common stock were disposed of under transaction code F, which the explanation states were withheld to satisfy tax obligations from restricted stock vesting.

At what price were the Concentra (CON) shares reported on the Form 4?

The 6,540 shares of Concentra Group Holdings Parent, Inc. common stock were reported at a price of $21.04 per share in the Form 4 filing.

How many Concentra Group Holdings Parent, Inc. (CON) shares does the insider own after this transaction?

Following the reported tax withholding transaction, the officer directly beneficially owned 113,460 shares of Concentra Group Holdings Parent, Inc. common stock.

What does transaction code F mean for the Concentra (CON) Form 4?

Transaction code F indicates a transaction where shares are withheld by the issuer, typically to cover tax obligations upon the vesting or exercise of equity awards, such as restricted stock. The explanation confirms this was to satisfy tax obligations from restricted stock vesting.

What is the role of the insider in Concentra Group Holdings Parent, Inc. (CON)?

The reporting person is an officer of Concentra Group Holdings Parent, Inc., serving as Executive Vice President, Chief Medical Officer, as stated in the remarks section.